Stay updated with breaking news from Ancer Lung . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Microbial diversity affects whether a tumor grows, leads to inflammation, develops immune escape mechanisms, or develops therapeutic resistance, said an internal medicine specialist.
The guidance also recommends counseling to help patients and providers who are struggling with 'psychological or moral distress' from ongoing shortages.
A comprehensive study exploring NSCLC subgroup responses to immunotherapy may help determine which patients are less likely to benefit from these agents.
"We are seeing some truly surprising response rates and progression-free survival data," says chairman of Unicancer and general director of the Léon Bérard Center in France.
The next-generation tyrosine kinase inhibitor provides a new treatment option for patients with this difficult-to-treat form of lung cancer.